- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01506180
In-Hospital Comprehensive Geriatric Assessment in Aged Acute Medical Patients
January 6, 2012 updated by: Merete Gregersen, University of Aarhus
The purpose of this study is to compare acute ill elderly medical patients in a geriatric department with general medical departments, and to examine the effects of comprehensive geriatric assessment in the geriatric setting compared with general medical care.
Study Overview
Status
Completed
Conditions
Detailed Description
Design:
1) a cross-sectional study followed by 2) a subgroup study by retrospective follow-up
Study Type
Observational
Enrollment (Actual)
3877
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Central Denmark Region
-
Aarhus, Central Denmark Region, Denmark, 8000
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
80 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Acute medical patients aged 80 years or older
Description
Inclusion Criteria:
- patients admitted to the departments of medicine at Aarhus University Hospital either through the emergency medical ward or directly to the medical wards in the period from January 1, 2009 to December 31, 2010.
Exclusion Criteria:
- patients admitted to the neurology-, cardiology-, nephrology- or haematology departments, and patients discharged directly to their homes from the emergency medical ward.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients admitted to Geriatric Department
The patients receive comprehensive geriatric assessment
|
Patients admitted to general medical departments
This group do not receive comprehensive geriatric assessment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comorbidity
Time Frame: At hospital admission (day 1)
|
By Charlsons Comorbidity Index
|
At hospital admission (day 1)
|
Length of hospital stay
Time Frame: Number of days of hospitalization an expected average of 8 days
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
|
Number of days of hospitalization an expected average of 8 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute readmission
Time Frame: 30 days and 90 days
|
The number of acute readmissions in the participants within 30 days and 90 days after the discharge, respectively.
|
30 days and 90 days
|
Mortality
Time Frame: Within 30 days after hospital admission
|
The number of short-term mortality in the participants within 30 days after hospital admission.
|
Within 30 days after hospital admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
November 2, 2011
First Submitted That Met QC Criteria
January 6, 2012
First Posted (Estimate)
January 9, 2012
Study Record Updates
Last Update Posted (Estimate)
January 9, 2012
Last Update Submitted That Met QC Criteria
January 6, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CGA-GD-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Disease
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedRecruitingGraft Versus Host Disease, AcuteUnited States, Australia, Turkey
-
Hospital de Clinicas de Porto AlegreRecruitingCritical Illness | Acute Kidney Injury | Fluid Overload | Renal Insufficiency, Acute | Volume Overload | Kidney; Disease, AcuteBrazil
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Sheba Medical CenterUnknownStem Cell Transplant Complications | Fecal Microbiota Transplantation | Graft Versus Host Disease, AcuteIsrael
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Israel, Spain, Germany, Belgium, Italy, Australia, France, Canada, Portugal
-
Jonsson Comprehensive Cancer CenterWithdrawnAcute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseUnited States
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.TerminatedAcute Myeloid Leukemia | Acute Leukemia | Acute Leukemia in Relapse | Relapsed or Refractory Acute LeukemiaChina
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of